scholar.google.com › citations
Although the effect of air pollution on MS pathogenesis remains not fully understood, exposure to polluted air can stimulate several mechanisms that might contribute to MS severity. People with MS with active disease have an altered microbiota compared to patients in the remission phase.
Aug 30, 2024 · In this study, we investigate the role of environmental factors in relapse occurrence among MS patients, using data from the H2020 BRAINTEASER project.
Oct 1, 2024 · (3) Results: Statistical analysis demonstrated that an increase in the level of cadmium was accompanied by an increase in the level of lead.
The finding this study showed is that toxic air pollutants can have synergistic and aggravating properties in increasing cases of multiple sclerosis.
Missing: Exploring | Show results with:Exploring
The aim of this study was to explore the link between air quality and MS relapses in patients who suffer from MS.
Missing: Progression. | Show results with:Progression.
People also ask
How do environmental factors affect multiple sclerosis?
Can environmental toxins cause MS?
What environmental pollutants affect the risk of neurological disorders?
Aug 30, 2024 · In this study, we investigate the role of environmental factors in relapse occurrence among MS patients, us- ing data from the H2020 BRAINTEASER ...
Exploring the Impact of Environmental Pollutants on Multiple Sclerosis ...
jglobal.jst.go.jp › detail
Article "Exploring the Impact of Environmental Pollutants on Multiple Sclerosis Progression" Detailed information of the J-GLOBAL is an information service ...
Sep 1, 2024 · The research paper explores how environmental pollutants may influence the progression of multiple sclerosis (MS), a chronic autoimmune disease ...
Sep 2, 2024 · Multiple Sclerosis (MS) is a chronic autoimmune and inflammatory neurological disorder characterised by episodes of symptom exacerbation, ...
Main Themes: Common Environmental Risk Factors: Investigate shared environmental factors that have been associated with disease progression in both MS and ALS.